Enliven Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 52k | 20.47 |
| 2025-06-30 | $1.7M | 83k | 20.06 |
| 2025-03-31 | $707k | 36k | 19.68 |
| 2024-12-31 | $984k | 44k | 22.50 |
| 2024-09-30 | $668k | 26k | 25.54 |
| 2024-06-30 | $543k | 23k | 23.37 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas